Lakshmi N, Kumar A G, Anand T, Reddy B K
Dept. of Microbiology, S.V. Medical College, Andra Pradash, India.
Indian J Cancer. 1993 Dec;30(4):189-91.
Serum samples were collected from 140 cancer cervix patients aged between 25-60 years and also from 20 age matched, married, healthy women to serve as controls. These sera were tested for HSV-2 antibodies by ELISA test and HBsAg by RPHA test. HSV-2 antibodies were detected in 92 (65-71%) and HBsAg in 25 (17.8%) cancer cervix patients. Sera from control group were negative for HSV-2 antibodies and HBsAg.
